Jump to: navigation, search
Carbenoxolone 3D ball.png
Systematic (IUPAC) name
(3β)-3-[(3-carboxypropanoyl)oxy]-11-oxoolean-12-en-30-oic acid
(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-(3-carboxypropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid
CAS number 5697-56-3
ATC code A02BX01
PubChem 636403
DrugBank DB02329
Chemical data
Formula C34H50O7 
Mol. mass 570.765 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability ?
Metabolism ?
Half life ?
Excretion ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes ?

WikiDoc Resources for Carbenoxolone


Most recent articles on Carbenoxolone

Most cited articles on Carbenoxolone

Review articles on Carbenoxolone

Articles on Carbenoxolone in N Eng J Med, Lancet, BMJ


Powerpoint slides on Carbenoxolone

Images of Carbenoxolone

Photos of Carbenoxolone

Podcasts & MP3s on Carbenoxolone

Videos on Carbenoxolone

Evidence Based Medicine

Cochrane Collaboration on Carbenoxolone

Bandolier on Carbenoxolone

TRIP on Carbenoxolone

Clinical Trials

Ongoing Trials on Carbenoxolone at Clinical

Trial results on Carbenoxolone

Clinical Trials on Carbenoxolone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Carbenoxolone

NICE Guidance on Carbenoxolone


FDA on Carbenoxolone

CDC on Carbenoxolone


Books on Carbenoxolone


Carbenoxolone in the news

Be alerted to news on Carbenoxolone

News trends on Carbenoxolone


Blogs on Carbenoxolone


Definitions of Carbenoxolone

Patient Resources / Community

Patient resources on Carbenoxolone

Discussion groups on Carbenoxolone

Patient Handouts on Carbenoxolone

Directions to Hospitals Treating Carbenoxolone

Risk calculators and risk factors for Carbenoxolone

Healthcare Provider Resources

Symptoms of Carbenoxolone

Causes & Risk Factors for Carbenoxolone

Diagnostic studies for Carbenoxolone

Treatment of Carbenoxolone

Continuing Medical Education (CME)

CME Programs on Carbenoxolone


Carbenoxolone en Espanol

Carbenoxolone en Francais


Carbenoxolone in the Marketplace

Patents on Carbenoxolone

Experimental / Informatics

List of terms related to Carbenoxolone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Carbenoxolone (CBX) is a glycyrrhetinic acid derivative with a steroid-like structure, similar to substances found in the root of the licorice plant. Carbenoxolone is used for the treatment of peptic, esophageal and oral ulceration and inflammation. Electrolyte imbalance is a serious side effect of carbenoxolone when used systemically.[1]

Carbenoxolone reversibly inhibits the conversion of cortisol to the inactive metabolite cortisone by blocking 11β-hydroxysteroid dehydrogenase (11β-HSD). 11β-HSD also reversibly catalyzes the conversion of 7-ketocholesterol to 7-beta-hydroxycholesterol. [2][3]

Carbenoxolone is a modestly potent, reasonably effective, water-soluble blocker of gap junctions.[4]

Nootropic effects

Carbenoxolone has also been investigated for nootropic effects.[5] This research started from an observation that long-term exposure to glucocorticoids may have negative effects on cognition. Carbenoxolone may decrease the amount of active glucocortocoid in the brain, because the drug inhibits 11β-HSD, an enzyme which regenerates cortisol, an active glucocorticoid, from inactive cortisone.

In the research trial investigating this use of carbenoloxone, it was shown that the drug improved verbal fluency in elderly healthy men (aged 55–75). In type 2 diabetics aged 52–70, the drug improved verbal memory. However, potassium-sparing diuretic amiloride was co-administered with carbenoxolone, since carbenoxolone used by itself may cause hypertension by increasing cortisol in the kidneys.